Fig. 2: Overall survival from the time of DR/INT (OS-2).
A the full cohort, (B) cohort stratified by INT (red) or DR (blue). C Progression free survival (PFS) for patients rechallenged with anti-PD-1 based therapy (red) or BV based therapy (blue).
Fig. 2: Overall survival from the time of DR/INT (OS-2). | Blood Cancer Journal
